These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 12208348)

  • 1. Lipid peroxidation in aging brain and Alzheimer's disease.
    Montine TJ; Neely MD; Quinn JF; Beal MF; Markesbery WR; Roberts LJ; Morrow JD
    Free Radic Biol Med; 2002 Sep; 33(5):620-6. PubMed ID: 12208348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases.
    Montine KS; Quinn JF; Zhang J; Fessel JP; Roberts LJ; Morrow JD; Montine TJ
    Chem Phys Lipids; 2004 Mar; 128(1-2):117-24. PubMed ID: 15037157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. F2-isoprostanes in Alzheimer and other neurodegenerative diseases.
    Montine TJ; Montine KS; McMahan W; Markesbery WR; Quinn JF; Morrow JD
    Antioxid Redox Signal; 2005; 7(1-2):269-75. PubMed ID: 15650414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on acrolein.
    Singh M; Dang TN; Arseneault M; Ramassamy C
    J Alzheimers Dis; 2010; 21(3):741-56. PubMed ID: 20634576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients.
    Montine TJ; Markesbery WR; Zackert W; Sanchez SC; Roberts LJ; Morrow JD
    Am J Pathol; 1999 Sep; 155(3):863-8. PubMed ID: 10487843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures.
    Lovell MA; Xie C; Markesbery WR
    Neurobiol Aging; 2001; 22(2):187-94. PubMed ID: 11182468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo.
    Bassett CN; Neely MD; Sidell KR; Markesbery WR; Swift LL; Montine TJ
    Lipids; 1999 Dec; 34(12):1273-80. PubMed ID: 10652986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neurobiology of isoprostanes and Alzheimer's disease.
    Praticò D
    Biochim Biophys Acta; 2010 Aug; 1801(8):930-3. PubMed ID: 20116452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease.
    Williams TI; Lynn BC; Markesbery WR; Lovell MA
    Neurobiol Aging; 2006 Aug; 27(8):1094-9. PubMed ID: 15993986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sign of lipid peroxidation as measured in the urine of patients with probable Alzheimer's disease.
    Tuppo EE; Forman LJ; Spur BW; Chan-Ting RE; Chopra A; Cavalieri TA
    Brain Res Bull; 2001 Mar; 54(5):565-8. PubMed ID: 11397549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease.
    Reich EE; Markesbery WR; Roberts LJ; Swift LL; Morrow JD; Montine TJ
    Am J Pathol; 2001 Jan; 158(1):293-7. PubMed ID: 11141503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid peroxidation in neurodegeneration: new insights into Alzheimer's disease.
    Arlt S; Beisiegel U; Kontush A
    Curr Opin Lipidol; 2002 Jun; 13(3):289-94. PubMed ID: 12045399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of brain lipid peroxidation by CSF drainage in Alzheimer's disease patients.
    Praticò D; Yao Y; Rokach J; Mayo M; Silverberg GG; McGuire D
    J Alzheimers Dis; 2004 Aug; 6(4):385-9; discussion 443-9. PubMed ID: 15345808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. End products of lipid peroxidation in erythrocyte membranes in Alzheimer's disease.
    Skoumalová A; Mádlová P; Topinková E
    Cell Biochem Funct; 2012 Apr; 30(3):205-10. PubMed ID: 22161584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoproteins and lipid peroxidation in Alzheimer's disease.
    Bassett CN; Montine TJ
    J Nutr Health Aging; 2003; 7(1):24-9. PubMed ID: 12679837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catecholamines inhibit lipid peroxidation in young, aged, and Alzheimer's disease brain.
    Andorn AC; Pappolla MA
    Free Radic Biol Med; 2001 Aug; 31(3):315-20. PubMed ID: 11461768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer's disease.
    Völkel W; Sicilia T; Pähler A; Gsell W; Tatschner T; Jellinger K; Leblhuber F; Riederer P; Lutz WK; Götz ME
    Neurochem Int; 2006 Jun; 48(8):679-86. PubMed ID: 16483694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo.
    Praticò D; MY Lee V; Trojanowski JQ; Rokach J; Fitzgerald GA
    FASEB J; 1998 Dec; 12(15):1777-83. PubMed ID: 9837868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures.
    Lovell MA; Xie C; Markesbery WR
    Free Radic Biol Med; 2000 Oct; 29(8):714-20. PubMed ID: 11053772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crotonaldehyde accumulates in glial cells of Alzheimer's disease brain.
    Kawaguchi-Niida M; Shibata N; Morikawa S; Uchida K; Yamamoto T; Sawada T; Kobayashi M
    Acta Neuropathol; 2006 May; 111(5):422-9. PubMed ID: 16538519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.